| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.072 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |